Colon | Rectum | Stomach

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

Volunteers
Health Professionals

What is the purpose of this trial?

This study will evaluate the role of mass-based response testing (MRT) to select and deliver personalized hyperthermic intraperitoneal chemotherapy (HIPEC) regimens to patients with peritoneal metastasis (PM) from high-grade appendiceal adenocarcinomas (HGAA) and colorectal cancer (CRC).

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Rodolfo Nelson Molina

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Kiran Turaga, MD, MPH
Professor of Surgery (Oncology); Division Chief, Surgical Oncology, Surgery; Assistant Medical Director, Clinical Trials Office

Sub-Investigators

Last Updated
02/22/2026
Study HIC
#2000038133